Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inopha International is primarily a pharmaceutical export and service provider specializing in Active Pharmaceutical Ingredients (APIs), finished dosage forms (FDFs), and pharmaceutical intermediates. Its research arm, Ningbo Inopha Biotec, focuses on the development of biosimilars, new dosage forms, and combination therapies. The company maintains a broad portfolio of commercialized generic products ranging from anti-infectives to cardiovascular and memory-enhancing medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inopha International.